Cas:203245-16-3 2,3,4-Trifluoroanisole manufacturer & supplier

We serve Chemical Name:2,3,4-Trifluoroanisole CAS:203245-16-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,3,4-Trifluoroanisole

Chemical Name:2,3,4-Trifluoroanisole
CAS.NO:203245-16-3
Synonyms:2,3,4,5,6-PENTAFLUOROPHENYL 1-ETHANESULPHONATE;Methyl 2,3,4-trifluorophenyl ether;MFCD00042396;2,3,4-Trifluoroanisole;10656662;1,2,3-Trifluoro-4-methoxybenzene;Benzene, 1,2,3-trifluoro-4-methoxy-;FR BF CF DO1
Molecular Formula:C7H5F3O
Molecular Weight:162.109
HS Code:2909309090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:155.5±35.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.435
PSA:9.23000
Exact Mass:162.029251
LogP:2.22

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN3271
Packing Group:III


Contact us for information like 2,3,4,5,6-PENTAFLUOROPHENYL 1-ETHANESULPHONATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,FR BF CF DO1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 2,3,4-trifluorophenyl ether Use and application,2,3,4-Trifluoroanisole technical grade,usp/ep/jp grade.


Related News: The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. 2,3,4-Trifluoroanisole manufacturer Patients given the vaccine also experienced a reduction in cerebrospinal fluid biomarkers of abnormal tau, results show. 2,3,4-Trifluoroanisole supplier Patients given the vaccine also experienced a reduction in cerebrospinal fluid biomarkers of abnormal tau, results show. 2,3,4-Trifluoroanisole vendor European companies are the main suppliers of specialty APIs, but due to environmental and cost pressures, APIs have begun to shift to the Asian market. 2,3,4-Trifluoroanisole factory The April halt followed the discovery that ingredients from AstraZeneca’s (AZN.L) COVID-19 vaccine, also being produced at the plant at the time, contaminated a batch of J&J’s vaccine. AstraZeneca’s shot is no longer being made there.